Vimarsana
Biggest News Aggregation in the World

Page 3 - David Schull News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Schull. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Schull Today - Breaking & Trending Today

Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Vimarsana News

Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

29.02.2024 -     Achieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022 Achieved Record Fourth Quarter 2023 Total Revenues of $110.6 Million, an 82.0% Increase Compared to Fourth Quarter 2022 Reported 2023 GAAP ...

Clene Presents Clinical Results of CNM-Au8® 30mg Treatment From Visionary-MS Trial Long-Term Extension at Annual ACTRIMS Forum 2024 - Vimarsana News

Clene Presents Clinical Results of CNM-Au8® 30mg Treatment From Visionary-MS Trial Long-Term Extension at Annual ACTRIMS Forum 2024

Long-term CNM-Au8 treatment demonstrated significant and clinically meaningful improvement of vision as measured by low contrast letter acuity (LC...

BioXcel Therapeutics Announces Termination of Proposed Public Offering - Vimarsana News

BioXcel Therapeutics Announces Termination of Proposed Public Offering

NEW HAVEN, Conn., Feb. 13, 2024 -- BioXcel Therapeutics, Inc. , a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and...

Zevra Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference - Zevra Therapeutics (NASDAQ:ZVRA) - Vimarsana News

Zevra Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference - Zevra Therapeutics (NASDAQ:ZVRA)

CELEBRATION, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that it will present at the upcoming Oppenheimer

Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Vimarsana News

Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

DALLAS, Feb. 06, 2024 -- Spectral AI, Inc. , an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that...